1.Lee M, Dukat M, Liao L, Flammia D, Damaj MI, Martin B, Glennon RA.. (2002) A comparison of the binding of three series of nicotinic ligands., 12 (15):[PMID:12113825][10.1016/s0960-894x(02)00298-6]
2.Cosford ND, Bleicher L, Herbaut A, McCallum JS, Vernier JM, Dawson H, Whitten JP, Adams P, Chavez-Noriega L, Correa LD, Crona JH, Mahaffy LS, Menzaghi F, Rao TS, Reid R, Sacaan AI, Santori E, Stauderman KA, Whelan K, Lloyd GK, McDonald IA.. (1996) (S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors., 39 (17):[PMID:8765504][10.1021/jm960328w]
3.Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA.. (2005) 3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands., 15 (19):[PMID:16039854][10.1016/j.bmcl.2005.06.053]
4.Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA.. (2005) 3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands., 15 (19):[PMID:16039854][10.1016/j.bmcl.2005.06.053]
5.Dukat M, Ramunno A, Banzi R, Damaj MI, Martin B, Glennon RA.. (2005) 3-(2-Aminoethyl)pyridine analogs as alpha4beta2 nicotinic cholinergic receptor ligands., 15 (19):[PMID:16039854][10.1016/j.bmcl.2005.06.053]